MetLife Posts Strong Quarter, ROE Hits Top Target

Metlife ((MET)) has held its Q1 earnings call. Read on for the main highlights of the call.

MetLife opened its latest earnings call on a confident note, pointing to a strong quarter marked by broad-based revenue growth, higher margins, and disciplined expense and capital management. Management acknowledged some headwinds in investment results, spreads, and certain regional items, but consistently framed these as manageable or temporary against what they described as durable momentum.

Robust Adjusted Earnings and EPS Expansion

MetLife reported adjusted earnings of $1.6 billion and adjusted EPS of $2.42, up 18% and 23% year over year respectively. The company emphasized that this performance reflects not just favorable markets but underlying operational strength across multiple lines of business.

Return on Equity at Top of Target Range

Adjusted return on equity reached 17%, hitting the top end of MetLife’s 15% to 17% target range and comfortably clearing its cost of capital. Executives framed this as evidence that recent investments and portfolio decisions are translating into attractive shareholder returns.

Broad-Based Revenue and Top-Line Momentum

Adjusted premiums, fees, and other revenues, excluding pension risk transfers, rose 10% from a year earlier, with gains spread across businesses and regions. Management underscored that this growth is not dependent on any single product or geography, which they see as a key de-risking factor.

Variable Investment Income Outperformance

Variable investment income once again surprised to the upside, with pretax VII of $518 million marking a third consecutive beat versus expectations. Private equity delivered returns of about 2.9% and venture capital 6.8%, supported by a total VII asset base of $18.2 billion.

Expense Discipline Ahead of Schedule

The direct expense ratio improved to 11.9%, already better than MetLife’s 2026 full-year target of 12.1% despite integrating PineBridge, a higher-expense asset manager. Management highlighted this as proof that cost actions and scale efficiencies are taking hold faster than planned.

Strong Capital Return and Balance Sheet Strength

MetLife returned roughly $1.1 billion to shareholders in the quarter, split between about $750 million of share repurchases and roughly $370 million in dividends. The company also issued $1 billion of subordinated debt, which was more than five times oversubscribed, and finished the quarter with $3.9 billion of holding-company cash.

Asia and EMEA Drive Segment-Level Outperformance

Asia delivered adjusted earnings of $487 million, up 31% year over year, with sales climbing 22% on a constant currency basis, led by Japan and Korea. EMEA posted adjusted earnings of $110 million, up 33%, as adjusted premiums, fees, and other revenues rose 15% and sales increased 17% in constant currency.

Growth in Group Benefits and Retirement Solutions

Group Benefits adjusted earnings reached $439 million, up 19%, with sales rising 15% and persistency remaining in the high 90s. Retirement & Income Solutions delivered $451 million of adjusted earnings, up 11%, and total investment spread of 119 basis points, at the top of the guided range.

Early Progress Integrating PineBridge into MIM

MetLife Investment Management posted adjusted earnings of $47 million, a 68% year-over-year increase, as the PineBridge integration gains traction. Management pointed to a robust pipeline in private assets and new international distribution avenues, noting that about half of PineBridge’s assets under management sit outside the U.S.

High-Quality Private Asset Portfolio

The company highlighted an $85 billion private fixed income portfolio, roughly 95% of which is investment grade, as a key risk anchor. MetLife reported no exposure to business development companies and less than 1% of the general account in middle market loans, stressing its limited exposure to higher-risk credits.

Investment and Trading Losses Temper Net Income

While adjusted earnings were strong, net income of $1.1 billion, or $1.74 per share, lagged due to net investment losses tied to trading activity. The quarter also included a modest loss on the opportunistic sale of roughly $750 million of private equity at a discount, which management framed as balance-sheet positioning.

Corporate and Other Segment Drag

Corporate and Other reported an adjusted loss of $177 million, wider than the $129 million loss a year earlier, reflecting foregone earnings from past strategic reinsurance and lower recurring interest margins. Less favorable expense margins also weighed, though these factors were partly offset by higher variable investment income.

MIM AUM Pressure and Integration-Related Outflows

Institutional assets under management declined about 1.9% sequentially, with approximately $2 billion of institutional outflows during the quarter amid market volatility and platform integration activity. Management expects integration-related expense elevation and related noise to be temporary and to normalize as PineBridge onboarding continues.

Latin America and Seasonal Capital Dynamics

Latin America adjusted earnings grew 5% year over year but fell 9% in constant currency due to the impact of prior-year tax changes in Mexico. Estimated U.S. statutory adjusted capital stood near $16.2 billion, down about 5% from year-end primarily because of seasonal dividends paid from U.S. entities.

Non-Medical Health and Disability Pressure Points

The nonmedical health interest-adjusted benefit ratio came in at 75.8%, just above the 70% to 75% annual target range, driven by higher dental utilization and elevated disability severity. New state-mandated paid family leave programs also increased incidence, while long-term disability severity remained slightly elevated versus last year but flat sequentially.

Spread and Yield Headwinds in RIS

Core spread excluding VII in Retirement & Income Solutions was 95 basis points, down roughly 4 basis points sequentially after portfolio rotations following sizable fourth-quarter inflows. Management cautioned that a persistently flat yield curve, with short rates elevated, could limit near-term spread improvement even as they manage new business pricing.

Regulatory, Legal, and Geopolitical Monitoring

MetLife noted it has divested its Ukraine business after what it called a difficult decision and is navigating industry-wide regulatory reviews in Japan related to secondments. The company also referenced an external press release alleging indemnity claims, which it characterized as baseless, while acknowledging the potential for contingent exposure.

Guidance Reinforces Confidence in Multi-Year Targets

Management reaffirmed key targets, including an adjusted ROE range of 15% to 17%, a 2026 direct expense ratio goal of 12.1%, and RIS full-year adjusted earnings of $1.6 to $1.8 billion with total spreads between 100 and 120 basis points. The company reiterated its 65% to 75% free cash flow conversion target, holding-company liquidity goal of $3 to $4 billion, and ongoing capital return plans supported by a robust risk-based capital position.

MetLife’s earnings call painted the picture of a company leveraging diversified growth, strong capital, and tight expense control to deliver double-digit earnings and EPS gains. While acknowledging investment, spread, and regulatory headwinds, management repeatedly emphasized their transitory nature, leaving investors with an overall impression of solid momentum and disciplined execution.